Expanded team to support development and commercialisation of precision antibiotics to help overcome antimicrobial resistance Glox Therapeutics, a company pioneering the development of precision ...

Microsoft security researchers analyze suspicious files to determine if they are threats, unwanted applications, or normal files. Submit files you think are malware or files that you believe have been ...

Congressman Ro Khanna urges Defense Secretary Pete Hegseth that the U.S. should not strike Iran unless Iran attacks the US first. He raised concerns that the U.S. would be dragged into a war and ...

Juggling isn’t just for show—it’s a practical training tool that can enhance coordination, focus, and foot control in soccer. This article explains how to incorporate juggling into your training ...

Avi Gabbay hopes you never have to use the skills and knowledge you learn from the club he recently founded – Glox and Barrels, a Jewish shooting and safety club in Columbus. “This is not a store or a ...

Like what you just read? Support Flagpole by making a donation today. Every dollar you give helps fund our ongoing mission to provide Athens with quality, independent journalism.

Glasgow-based Glox Therapeutics, a company that aims to advance its precision antibiotic therapies, focusing on naturally occurring bacteriocins, has secured £4.3M (approximately €4.93M) in a seed ...

Altmetric provides a collated score for online attention across various platforms and media. See more details Chromocenters are established after the 2-cell (2C) stage during mouse embryonic ...

Glox Therapeutics has appointed of Michael Murray as chair of its board. He will work with the leadership team to accelerate the Glasgow-based company’s growth and help guide the commercialisation of ...

Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, today announced the appointment of Dr Michael Murray as Chair of ...

GLASGOW, Scotland--(BUSINESS WIRE)--Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, today announced the appointment ...